Histone deacetylase inhibitor gel shows promise for the treatment of patients with basal cell carcinoma LiveStream Saturday, August 07, 2021 Science Leave a Reply Remetinostat, a topical cream and first-in-class inhibitor of histone deacetylation, showed signs of clinical efficacy in patients with basal cell carcinoma. source https://www.sciencedaily.com/releases/2021/08/210806104354.htm
0 comments: